Speed up the Development of and Access to Innovative Medical Countermeasures: Next-Generation Influenza Vaccines

Health and Digital Executive Agency (HaDEA)

About

The Health and Digital Executive Agency (HaDEA) addresses the European Commission’s ambition to help rebuild a post-COVID-19 Europe at its heart, which will be greener, more digital and more resilient. It has launched a call for tenders of an estimated budget of €225 000 000 under the EU4Health Programme.  This call will be implemented in three distinct phases.

The Challenge

The challenge focuses on accelerating the development of next-generation influenza vaccines that can be rapidly produced, broadly protective, and adaptable to emerging pandemic threats. A key objective is to develop vaccine candidates that are either intrinsically immunogenic or effective without the need for adjuvants, thus simplifying formulation and potentially accelerating regulatory pathways. By fostering such innovations, the procurement aims to strengthen pandemic preparedness and reduce reliance on slower, conventional vaccine platforms, positioning Europe at the forefront of resilient and responsive immunisation strategies.

Timeframe

Interested parties are invited to apply via the Funding and Tenders Portal by May 19^h, 2025, 15:00 (UTC+2) Eastern European Time, Central European Summer Time

Who can apply

The tender is open to small and medium-sized enterprises (SMEs), as well as other entities, as as specified in the procedure's descriptive document.

How to apply

You can find all the details of the procedure here.

The SPIN4EIC consortium is not responsible for the challenges launched by private or public buyers. Each participating entity is solely responsible for its own challenge, including the selection process, communication with applicants, and all information provided to participants.